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Purpose: The purpose of this study was to review the complications of transaxillary 
arteriography (TRAX), determine clinical factors associated with their occurrence, and 
define optimal treatment methods. 
Methods: A retrospective r view of 842 consecutive TRAX studies performed in a large, 
urban, tertiary care, academic medical center was undertaken. Patients with complications 
were compared with a concurrent randomized control group without complications with 
the use of a multivariate analysis model. Results of operative therapy for nerve injury were 
compared with those of nonoperative therapy. 
Results: Nineteen (2.3%) complications were identified including 14 nerve injuries, four 
expanding hematomas/pseudoaneurysms without neurologic deficit, and one puncture 
site thrombosis. Several statistically significant or suggestive findings associated with the 
occurrence of complications were identified: female sex (odds ratio [OR] = 4.7), systolic 
blood pressure _>150 mm Hg at the conclusion of TRAX (OR = 9.5), periprocedural 
systemic heparin anticoagulation (OR = 7.9), concomitant use of intraarterial throm- 
bolysis or percutaneous angioplasty (OR = 12.0), and duration of procedure >90 minutes 
(OR = 4.0). Patients who underwent prompt exploration (<4 hours from symptom onset) 
for nerve injuries were more likely to have complete resolution of their neurologic deficits 
(five of six patients) than those who were observed or underwent delayed operation (three 
of eight patients) (OR = 8.3). 
Conclusions: Aggressive treatment of post-TRAX hypertension, limitation of TRAX 
duration, delay of postprocedure anticoagulation, and use of alternative sites for arterial 
puncture in female patients or patients undergoing catheter-based intervention may reduce 
the incidence of TRAX-related complications. In patients who have neurologic deficits 
prompt surgical exploration of the ptmcture site with decompression f the involved 
nerve(s) may reduce the incidence of prolonged eficits. (J Vasc Surg 1996;23:844-50.) 
Transaxillary arterial catheterization is a well estab- 
lished, practical, and safe approach for diagnostic and 
therapeutic procedures when transfemoral ccess is 
not possible or undesirable. Nevertheless complica- 
tions such as hematoma formation with nerve injury, 
arterial thrombosis, distal embolism, pseudoaneu- 
rysm formation, and arteriovenous fi tula have been 
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described. >1° Mthough several reports have charac- 
terized the nature and incidence of these complica- 
tions, none has evaluated factors associated with their 
occurrence. 
Nerve injury caused by compression from local 
bleeding is the most common and potentially debili- 
tating complication after transaxillary arteriography 
(TRAX). Because of  the close proximity of the distal 
axillary and proximal brachial arteries to the brachial 
plexus, even a small puncture site hematoma can 
produce significant nerve compression and dysfunc- 
tion. In addition, optimal management of these 
injuries is unclear, with some authorities advocating 
prompt exploration for any neurologic deficit 1-4 and 
others reserving operative decompression for motor 
deficits only. s'6 This study was undertaken i part to 
clarify this debate. 
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MATERIAL AND METHODS 
Patients with complications after undergoing 
TRAX were identified through the database of the 
Henry Ford Hospital Vascular Surgery Registry and 
the records of the Special Procedures Division of the 
Department of Diagnostic Radiology over a 9-year 
period from January 1, 1986, through December 31, 
1994. Data collected for each patient included the 
nature of the complication, demographic profile, 
factors related to the performance of TRAX, treat- 
ment selected for the complication, and the outcome 
of the complication. The specific demographic, 
periprocedural, and procedure-related factors in- 
cluded age, sex, race, height, weight, body mass index 
(wt(kg)/ht(m)2), antithrombotic therapy, antihyper- 
tensive therapy, side of puncture, blood pressure at 
the beginning and end of the procedure, diagnostic 
study performed, indication for the study, interven- 
tional procedure performed, if any, duration of the 
procedure, number of catheters used, and size of the 
largest catheter used. 
All patients undergoing TRAX were tested for 
routine coagulation parameters before the procedure. 
In all patients considered in the study (cases + control 
group), the prothrombin time was less than 15 
seconds (normal 11 to 14 seconds), the activated 
partial thromboplastin time was within the normal 
range, and the platelet count was more than 80,000. 
Patients receiving systemic heparin anticoagulation 
were taken offheparin infusion at least 4 hours before 
undergoing TRAX. 
Nerve injuries after TRAX were diagnosed by the 
presence of sensory deficits, motor deficits, or both 
within the distribution of the median, ulnar, or radial 
nerves. Recovery from nerve injury was considered 
complete when all sensory and motor deficits had 
resolved at last follow-up or incomplete when sensory 
or motor deficits remained at last follow-up. The time 
from symptom onset o resolution was recorded for 
those patients with complete recovery. Symptom 
resolution was evaluated with respect o treatment 
with an odds ratio (OR) with 95 % confidence interval 
(CI) and Fisher's exact est. 
The selected management of TRAX complica- 
tions was at the discretion of the attending vascular 
surgeon. Management options were divided into 
observation, prompt exploration (operation per- 
formed _<4 hours from onset of symptoms), or de- 
layed exploration (operation performed >4 hours 
from onset of symptoms). The time from the onset 
of neurologic symptoms to operation was recorded 
for each patient. Operative intervention for nerve 
injury and more obvious bleeding complications 
(pseudoaneurysm or expanding hematoma) con- 
sisted of exposure of the arterial puncture site, careful 
hematoma evacuation, and arterial repair. 
For each patient in whom a TRAX complication 
occurred, four patients undergoing TRAX without 
complication were randomized as a control group for 
comparison of the study parameters. One patient in 
the control group was eventually excluded, because 
his puncture site was the distal brachial rather than the 
proximal brachial artery. Comparisons between pa- 
tients with TRAX complications and patients in the 
control group were made with OR with 95% CI and 
g 2 analysis for conditional variables and ORwith 95% 
CI and t test for continuous variables. Multivariate 
logistic regression analysis was then performed to test 
the independence of associations found by univariate 
analysis. Results are expressed as adjusted OR with 
95% C1 and as adjusted g 2 values. No significant 
differences between study cases and the control group 
were found when the indication for procedure, an- 
giographer, or calendar year in which the study was 
performed were considered. 
RESULTS 
During the 9-year study period 842 transaxillary 
procedures were performed in 674 patients. Five 
hundred forty-nine patients had one transaxillary 
procedure performed uring the study period. One 
hundred twenty-five patients underwent more than 
one study. This group included two TRAX (95), three 
TRAX (21), four TRAX (six), five TRAX (two), and 
six TRAX in a single patient. Nineteen (2.3%) com- 
plications were identified in the 842 consecutive 
procedures and consisted of 14 (1.7%) nerve injuries, 
four (0.5%) bleeding complications without nerve 
injury (pseudoaneurysm or expanding hematoma), 
and one (0.1%) puncture site arterial thrombosis. The 
median nerve was affected in 9 (64%) of the 14 
patients, the ulnar nerve in 6 (43%), and the radial 
nerve in 1 (7%). Sensory deficits alone were noted in 
9 (64%) of 14 patients, whereas both sensory and 
motor deficits occurred in 5 (36%) (Table I). 
A puncture site hematoma was externally identi- 
fied in 10 (71%) of the 14 patients with nerve injuries. 
Eight of the 10 patients with identifiable hematomas 
and two of four patients without identifiable hemato- 
mas underwent surgical exploration, whereas the 
remaining four patients were observed. Operation 
was performed from 1.5 to 78 hours after the onset of 
neurologic symptoms (median, 3.5 hours). Nine of 
the 10 patients undergoing exploration for nerve 
injury had an uncomplicated operative procedure. 
The remaining patient had a radial nerve sensory and 
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Table I. Distribution of nerve injuries 
Median nerve only 
Median nerve and 
radial nerve 
Median nerve and 
ulnar nerve Ulnar nerve only Total (%) 
Sensory deficit on~ 4 0 0 5 9 (64) 
Sensory and motor 3 1 1 0 5 (36) 
deficits 
TotM (%) 7 (50) 1 (7) 1 (7) 5 (36) 14 
motor deficit after undergoing exploration for a 
median erve sensory deficit. 
Six of the 10 patients with nerve injuries under- 
going puncture site exploration and two of the four 
treated without operation had complete resolution of 
their neurologic deficits. One of the two patients 
without identifiable hematoma who were observed 
rccovered completely from the nerve injury. Five of 
the six patients who had complete return of nerve 
function after undergoing exploration had no symp- 
toms within 4 days of operation, whereas one indi- 
vidual had return of nerve function at 14 days after 
operation. One of two patients with complete return 
of nerve function after observation had no symptoms 
within 4 days after undergoing TRAX, whereas the 
other did not have resolution of neurologic deficits 
until 13 months after undergoing TRAX. The mean 
follow-up for patients with incomplete recovery of 
nerve function was 16.5 months. Nerve injuries and 
outcomes for the 14 affected patients are detailed in 
Table II. 
Urgent operations (<4 hours from onset of neu- 
rologic symptoms) were performed on six patients 
with nerve injury. Five (83.3%) of these patients had 
complete resolution of their neurologic deficits. 
Three (37.5%) of the eight patients treated with 
observation or delayed exploration (>4 hours after 
symptom onset) had complete nerve function recov- 
ery. Patients who underwent urgent puncture site 
exploration with hematoma evacuation and arterial 
repair were 8.3 times more likely to recover com- 
pletely from their nerve injury than patients observed 
or treated with delayed exploration (95% CI 0.5 to 
471.1) (p = 0.14). 
Puncture site exploration was recommended to
three of the four patients with pseudoaneurysms or 
expanding hematomas. The single patient treated 
without operation had a small puncture site pseudo- 
aneurysm without associated neurologic deficit. The 
pseudoaneurysm resolved without further therapy as 
documented by duplex scanning 1 month later. The 
patient with arterial thrombosis was not offered 
immediate operation because of the absence of 
ischemic symptoms. Within 1 week after TRAX was 
performed, this patient had regaincd normal pulses, 
suggesting recanalization fthe occluded segment or 
collateral compensation. 
Whereas a number of factors had a statistically 
significant association with the occurrence of TRAX 
complications by univariate analysis, in the multivari- 
ate logistic regression analysis model three factors 
remained significant (Table III). Female patients were 
4.7 times more likely to have a complication of TRAX 
than male patients (95% CI 1.0 to 21.8) (p < 0.05). 
Patients with a systolic blood pressure ___150 mm Hg 
at the conclusion of TRAX were 9.5 times more likely 
to have a complication than were those with a systolic 
blood pressure less than 150 mm Hg (95% CI 1.2 to 
75.5) (p < 0.04). When systemic heparin anticoagu- 
lation was used in the periprocedural period, patients 
were 7.9 times more likely to have a complication 
(95% CI 1.3 to 47.0) (p < 0.03). 
DISCUSSION 
Although the term "transaxillary arteriography" 
is used by convention, the actual puncture site for the 
procedures considered inthis report was the proximal 
brachial artery (Fig. 1). Because of the proximity of 
the brachial plexus to the distal axillary/proximal 
brachial artery, the potential for nerve injury with 
arterial puncture at this site is obvious. Injury to the 
nerves of the upper extremity as a result of TRAX 
occurred in 1.7% of patients in this study. Previous 
reports have recorded incidences ranging from 0.6% 
to 2.8%. x,5,7,8 This report may underestimate the true 
incidence of nerve injury, however, because of poten- 
tial problems in identification of deficits in patients 
undergoing outpatient procedures and possible lack 
of appreciation of symptoms by care providers. 
The relative frequency of dysfunction of the bra- 
chial nerves after TRAX probably results from their 
anatomic relationship to the distal axillary/proximal 
brachial artery (Figs. 1 and 2). The median erve has 
previously been reported to be at greatest risk with 
TRAX, 9 and this finding is confirmed by this report. 
The ulnar nerve was less frequently involved, and only 
one injury of the radial nerve was encountered. 
Nerve injuries after TRAX have been recognized 
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Table II. Details of nerve injuries in 14 patients after TRAX 
Time from Time from 
TRAX to onset symptom onset Time to complete 
of symptoms Deficit to exploration Residual resolution f Follow-up of
Patient (hr) type  Exploration (hr) deficit symptoms residual deficit 
1 5 Sensory and Yes 2 N /A  2 wk N/A  
motor 
2 29 Sensory Yes 5.5 Sensory N /A  20mo 
3 12 Sensory and Yes 3 Sensory and N/A  6mo 
motor motor 
4 2 Sensory Yes 1.5 N /A  <4days N /A  
5 24 Sensory Not offered N/A  Sensory N /A  9mo 
6 0 Sensory Refused N/A  Sensory N /A  26mo 
7 48 Sensory Not offered N/A  N /A  13 mo N/A  
8 24 Sensory Yes 4 N /A  <4days N /A  
9 0 Sensory Yes 78 Sensory N /A  2mo 
10 28 Sensory Refused N/A  N /A  <4days N /A  
11 26 Sensory and Yes 2 N /A  <4days N /A  
motor 
12 4 Sensory Yes 3 N /A  <4days N /A  
13 16 Sensory and Yes 8.5 Sensory and N/A  36mo 
motor motor 
14 34 Sensory and Yes 12 N/A  <4days N /A  
motor 
N/A, Not applicable. 
Table HI .  Factors evaluated in the multivariate model with crude odds ratios, crude p values, 
adjusted odds ratios, and adjusted p values 
No. of No. of Crude OR Crude p Adjusted OR Adjusted p 
Factor cases (%) controls (%) (95% CI) value (95% CI) value 
Age 63.9yr* 63.2yr* N /A  NS~ 1.0 (0.9-1.1) NS 
BMI 24.2kg/m 2. 25.6kg/m 2. N /A  NS t 0.9 (0.7-1.1) NS 
Blackrace 12/19 (63) 19/73 (26) 4.9 (1.5-16,6) 0.002 4.1 (0.8-22.2) 0.11 
Female sex 12/19 (63) 21/75 (28) 4.4 (1.5-12.7) 0.004 4.7 (1.0-21.8) 0.05 
Preprocedure SBP 13/19 (68) 36/73 (49) 2.3 (0.8-6.8) NS 0.4 (0.1-2.6) NS 
>150 mm Hg 
Postprocedure SBP 14/19 (74) 25/71 (35) 5.2 (1.5-20.1) 0.002 9.5 (1.2-75.5) 0.03 
>150 mm Hg 
Periprocedure sys- 8/19 (42) 9/72 (13) 5.1 (1.4-18.5) 0.003 7.9 (1.3-47.0) 0.02 
temic heparin 
Maximum catheter 6/19 (32) 13/75 (17) 2,1 (0.6-7.5) NS 0.8 (0.1-5.6) NS 
size >5.0 fr 
Two or more cath- 9/19 (47) 11/73 (15) 5.1 (1.4-17.5) 0.002 2.8 (0.3-23.8) NS 
eters used 
Duration ofproce- 11/19 (58) 13/69 (19) 5.9 (1.7-20.4) 0.001 4.0 (0.7-24.6) 0.13 
dure >90 min 
IATE and/or PTA 5/19 (26) 3/75 (4) 8.6 (1.8-40.0) 0.002 12.0 (0.6-224.0) 0.10 
BMI, Body mass index; N/A, not applicable; SBP, systolic blood pressure; IATT, intraarterial thrombolytic therapy; PTA, percutaneous, 
transfuminal angioplasty; NS, not significant or suggestive. 
*Mean values for group. 
t test. 
in the absence of an externally identifiable he- 
matoma, s The fascial sheath surrounding the neu- 
rovascular structures of the upper arm can prevent 
egress of blood into the subcutaneous tissues. Al- 
though historically this fascial sheath has been iden- 
tified as the axillary sheath, recent anatomic studies 
have focused attention on the medial brachial fascia, s 
This inelastic investing fascia of  the arm forms a 
compartment, the medial brachial fascial compart- 
ment, around the neurovascular structures of the 
upper arm with its extensions of fascia between 
muscle groups attaching to the humerus (Fig. 2). A 
relatively small hematoma within the medial brachial 
fascial compartment resulting from an arterial punc- 
ture may be enough to compress adjacent nerves yet 
be difficult to detect on physical examination. This 
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~ MEDIAN NERVE 
NERV~~ MUSCULOCUTANEOUS NERVE 
/ AXILLARY SHEATH 
v . , .  
AXILLARY ARTERY l _ .  PECTORALIS MAJOR 
Fig. 1. Typical puncture site for "transaxillary" studies and relationship of distal axillary and 
proximal brachial artery to brachial plexus. 
MEDIAL BRACHIAL 
FASCIAL 
COMPARTMEN~7~ 
RADIAL NERVE -~ 
~ ~  AXILLARY ARTERY 
~ ~ A \ ~ ~  AXILLARY VEIN 
~ ~' ~ LATISSIMUS DORSI 
\ 
Fig. 2. Relationships of ncurovascular structures of upper arm and configuration of medial 
brachial fascial compartment. 
description is consistent with operative findings of 
small subfascial hematomas in both patients who 
underwent exploration for nerve deficits without 
evidence of an externally detectable puncture site 
hematoma. 
Local anesthetic used before artcrial puncture may 
cause brachial plexus neurologic symptoms that are 
difficult to differentiate from symptoms resulting 
from nerve compression. In this study only 2 of the 14 
patients with nerve injuries had immediate nerve 
deficit after undergoing TRAX. When brachial nerve 
symptoms begin immediately after TRAX, it is advis- 
able to observe the patient for 2 to 3 hours to allow 
any local anesthetic effect o resolve before contem- 
plating exploration for a presumed nerve injury. 
Hypertension, 7 anticoagulation, 7'9 and perfor- 
mance ofpercutaneous transluminal ngioplasty 8 via 
the transaxillary oute have all been anecdotally asso- 
ciated with the development of complications. Al- 
though the association of an elevated blood pressure 
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at TRAX conclusion or the use of periprocedural 
anticoagulation with puncture site bleeding seems 
intuitively obvious, the basis for the independent 
association of complications with female sex is difficult 
to understand. I f  a size difference in patients ex- 
plained the correlation, factoring body mass index 
into the multivariate model would be expected to 
negate the association. At present no obvious expla- 
nation accounts for the association between female 
sex and TRAX complications. 
The use of multiple catheters, performance of 
percutaneous transluminal ngioplasty or intraarterial 
thrombolytic therapy during TRAX, and duration of 
TRAX for 90 minutes or greater were statistically 
associated with TRAX complications by univariate 
analysis. Independent statistical significance was lost 
when these closely related factors were considered 
together in the multivariate analysis model, although 
long procedure duration and transaxillary catheter- 
directed intraarterial thrombolytic therapy, or percu- 
taneous transluminal ngioplasty continued to have a 
suggestive association with complications. The logical 
explanation for this possible association is an increase 
in the potential for bleeding into the medial brachial 
fascial compartment related to the longer residence 
rime of a catheter through the arterial wall, the use of 
larger diameter catheters, and the use of antithrom- 
boric agents. 
A selective approach to puncture site exploration 
for nerve deficits after TRAX has been suggested by 
some authorities. With this approach operation is 
undertaken only when motor deficits S,6 or "severe" 
sensory or motor deficits are present. 8 Four patients in 
this series were observed with sensory deficits (two 
refused operation); two had complete resolution of 
their deficits, one early (<4 days) and one late (13 
months), and two had continued deficits 2 and 9 
months later. Five individuals underwent operation 
for sensory deficits alone. Three who underwent 
exploration within 4 hours of the onset of symptoms 
had complete deficit resolution of their deficits within 
4 days, whereas two had only partial recovery after 
undergoing delayed exploration. These results sug- 
gest hat even patients with sensory deficits alone may 
benefit from operative decompression. 
Prompt operation after development of an upper 
extremity neurologic deficit may result in immediate 
resolution of symptoms or hasten recovery of func- 
tion. ~° Individuals who underwent prompt explora- 
tion in this series were 8.3 times more likely to have 
complete recovery than patients who were either 
observed or underwent delayed operation, although 
the difference did not reach statistical significance. In 
addition, recovery ofneurologic function after timely 
exploration was rapid in most cases. As a result of  these 
observations prompt exploration for any sensory or 
motor nerve deficit after TRAX is suggested, because 
it appears to result in more complete and rapid 
recovery of nerve function. 
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DISCUSSION 
Dr. Jonathan B. Towne (Milwaukee, Wis.). When you 
think of the anatomy of the axillary contents, it is amazing 
that you can catheterize this vessel nestled by all these nerves 
with large-bore needles and only have complications in
2.3%, of which 1.7% were nerve injuries. I think the most 
important lesson in this article is that one should promptly 
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take these patients with brachial plexus symptoms to the 
operating room even despite lack of physical findings. The 
artery angiogram site should be explored and decom- 
pressed, if necessary. 
I do have several questions. Number one, I would like 
to ask, did the neurologic deficit correlate with the amount 
of hematoma? For example, if one has just a small he- 
matoma, is that more likely to have a sensory deficit versus 
a deficit hat involves both sensory and motor nerves? What 
was the cause of injury in these 4 of 14 patients who had 
negative xplorations? Could it be that indeed the needle 
itself somehow injured a nerve? Do you think it is some 
chemical irritation? 
Dr. Richard Chit-wood. The first question was, did the 
hematoma size correlate with the amount of deficit? We 
actually did not find that that was the case. In fact, we made 
no attempt to follow hematomas per se that did not develop 
a neurologic deficit or in which pseudoaneurysm was not a 
concern. There were many large hematomas that had no 
neurologic deficit, and certainly at exploration the serious- 
ness of nerve deficit did not seem to correlate with the 
amount ofhematoma. At exploration i all 10 patients who 
underwent surgery for neurologic deficit, all of those 
patients did indeed have hematoma surrounding the axillary 
artery. There were no patients who did not have any 
evidence of hematoma. There were patients who did not 
have evidence ofhematoma on external examination of the 
puncture site. 
As regards the recommendation to explore urgently, I 
think the evidence suggests hat may be the case. One group 
of patients we do not suggest operating on immediately is 
the group of patients who have their neurologic symptoms 
immediately at the conclusion of the procedure. Those 
patients sometimes have the effect of local anesthesia 
administered atthe time of their procedure, causing nerve 
deficits. We advocate actually that those patients be ob- 
served for 2 to 3 hours, and if their neurologic deficits do 
not resolve within that time, that they undergo exploration. 
Dr. Will iam D. Turnipseed (Madison, Wis.). Dr. 
Chitwood, you focused on physical findings such as the 
presence of a hematoma or neurologic defects as your red 
flags for some kind of interventional treatment. What you 
have not discussed is the prevalence of pain syndromes 
associated with transaxillary arteriography. Is this a common 
problem? Regarding surgical timing, is there a window 
beyond which you would not explore these patients, even if 
you are convinced that the injury is, as you have already 
described, the cause for the problem? 
Dr. Chitwood. With regards to pain syndrome, we did 
have one patient who eventually had reflex sympathetic 
dystrophy and bad pain syndrome in the upper extremity. 
However, most of the symptomatology has been purely on 
a neurologic basis in terms of motor deficit or sensory 
deficit, which is what this was based on. 
As regards the timing of operation, we have explored 
patients up to as late as 78 hours after the initial injury. That 
particular patient did not notify anybody that she was 
having symptoms after the arteriogram, and when they were 
recognized, she was explored promptly. However, the 
symptoms were there a long time. We have not set a limit, 
and I just do not know the answer to whether there is any 
benefit of exploration late. 
